Cerevel Therapeutics Holdings, Inc. (CERE)

NASDAQ: CERE · IEX Real-Time Price · USD

42.90

+0.20 (0.47%)

At close: Jul 19, 2024, 4:00 PM

44.98

+2.08 (4.85%)

Pre-market: Jul 22, 2024, 8:34 AM EDT

CERE Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	7,816	7,644	4,930	4,773	2,108	-
Market Cap Growth	100.88%	55.03%	3.29%	126.47%	-	-
Enterprise Value	7,450	7,132	4,463	4,274	1,753	-55
PE Ratio	-	-17.66	-14.03	-21.18	-14.21	-
PB Ratio	13.85	11.35	9.46	8.25	5.48	-
P/FCF Ratio	-20.70	-22.08	-16.59	-25.25	-15.42	-
P/OCF Ratio	-20.91	-22.33	-16.82	-26.73	-17.89	-
EV/EBITDA Ratio	-16.48	-17.14	-13.03	-19.20	-11.53	0.43
EV/EBIT Ratio	-16.27	-16.91	-12.85	-18.97	-11.50	0.43
EV/FCF Ratio	-19.71	-20.61	-15.02	-22.61	-12.82	0.77
Debt / Equity Ratio	0.85	0.71	0.82	0.12	0.09	0.37
Debt / EBITDA Ratio	-1.09	-1.16	-1.25	-0.31	-0.22	-0.22
Debt / FCF Ratio	-1.30	-1.39	-1.44	-0.37	-0.24	-0.40
Quick Ratio	10.09	10.77	12.32	13.40	13.13	5.63
Current Ratio	10.22	10.92	12.48	13.59	13.22	5.85
Interest Coverage	-42.46	-39.91	-88.68	-	-	-
Return on Equity (ROE)	-98.90%	-100.10%	-67.00%	-48.90%	-150.30%	-
Return on Assets (ROA)	-45.10%	-44.50%	-42.30%	-40.60%	-79.40%	-
Return on Capital (ROIC)	-46.85%	-38.74%	-38.80%	-33.92%	-35.71%	-78.57%
Earnings Yield	-5.89%	-5.66%	-7.13%	-4.72%	-7.03%	-
FCF Yield	-4.74%	-4.53%	-6.03%	-3.96%	-6.49%	-
Buyback Yield / Dilution	-15.94%	-7.13%	-10.76%	-85.46%	-66.58%	-
Total Shareholder Return	-15.94%	-7.13%	-10.76%	-85.46%	-66.58%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).